Catheter Precision Secures First Purchase Order in Croatia Following Tender Win
2025-09-10 13:30:26 ET
Catheter Precision, Inc. (NYSE: VTAK ), a U.S.-based medical device company specializing in cardiac electrophysiology, announced it has received its first purchase order from a hospital in Croatia after successfully winning a competitive tender bid.
Dubrava University Hospital in Zagreb, one of the country's leading medical institutions, had previously completed an evaluation of the company's VIVO system before placing it into the approval process. The bidding stage allowed the hospital to review competing technologies before finalizing its decision.
At the time of the evaluation, Dr. Ivan Zeljkovic, Head of the Electrophysiology Lab at Dubrava University Hospital, remarked, "The VIVO workflow is simple and flexible, and I was impressed with the accuracy of the VIVO maps which certainly exceeded my expectations! Having the VIVO maps pre-procedurally allowed us to accurately target the anatomic location of the ventricular arrhythmia and has the potential to increase procedural efficacy."
Dubrava University Hospital serves as both a treatment and research center, treating over 25,000 inpatients annually and providing more than 1.5 million healthcare services to around 400,000 outpatients. It is also recognized as a teaching hospital with several active research departments.
Commenting on the milestone, Fatih Ayoglu, Sales Manager for EMEA & APAC at Catheter Precision, stated, "This milestone represents more than just geographic expansion--it reflects the trust and enthusiasm of leading clinicians and partners across Europe who are embracing our technologies to elevate patient care. We're proud to collaborate with such forward-thinking institutions and physicians and look forward to continued growth across the region."
The order marks Catheter Precision's continued expansion into Europe, building on its mission to deliver advanced tools to support the treatment of complex cardiac arrhythmias.
About Catheter Precision
Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
This article contains sponsored content. Please see our disclaimer at: https://prismmarketview.com/disclaimer/
The post Catheter Precision Secures First Purchase Order in Croatia Following Tender Win appeared first on PRISM MarketView .
COMTEX_468683343/2927/2025-09-10T12:30:26
NASDAQ: VTAK
VTAK Trading
-7.73% G/L:
$1.37 Last:
121,216 Volume:
$1.40 Open:



